from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3198c/uvrD2

LFCtreatmentdescriptionclass of inhibitor

-0.261

Amikacinug/mL Amikacintranslation

-0.272

Cap5-10ug/mL Capreomycintranslation

-0.228

Rox10-50 ug/mL Roxithromycintranslation

-0.482

SM2-5 ug/mL Streptomycintranslation

0.131

Tet5-10 ug/mL Tetracyclinetranslation

0.431

Rif0.2-5ug/mL Rifampicintranscription

-0.680

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.841

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.941

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.126

CPZ10-50 ug/mL Chlorpromazinerespiration

0.327

Clofazimine10-13 ug/mL Clofaziminerespiration

0.125

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.915

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.862

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.733

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.260

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.557

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.380

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.453

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.477

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.830

KCN5-20 ug/mL Potassium cyaniderespiration

-0.777

NaN30.2-2 mM Sodium aziderespiration

-0.581

Nigericin50 uM Nigericinrespiration

-0.374

TRC10-150 ug/mL Triclosanrespiration

0.033

TRZ10-25 ug/mL Thioridazinerespiration

-1.594

Valinomycin0.5-10 uM Valinomycinrespiration

1.121

ZnSO42 mM ZnSO4respiration

0.432

menadione6-10 ug/mL Menadionerespiration

0.404

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.200

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.610

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.254

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.744

NRP_1Non-replicating persistence stage 1dosRassociated

0.370

Amp0.2mg/mL AmpicillincellWall

0.179

Cephalexin20-100 ug/mL CephalexincellWall

0.143

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.468

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.047

EMB10-20 ug/mL EthambutolcellWall

-0.012

Eta12-40 ug/mL EthionamidecellWall

-0.015

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.362

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.166

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.240

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.467

BZA0.12 mg/mL BenzamidearomaticAmides

-0.041

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.350

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.819

H2O24 mM hydrogen peroxideDNAdamaging

0.607

Levo10 ug/mL LevofloxacinDNAdamaging

0.387

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.344

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.734

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.887

UVUV-irradiationDNAdamaging

-0.059

ARP41-4 ug/mL Antitubercular compound ARP4?

0.079

Antimycin12.5-50 ug/mL Antimycin A?

-0.056

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.081

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.483

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.188

PA8240.2-2 ug/mL PA-824?

-0.931

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.120

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.364

Verapamil50 uM Verapamil?

-0.704

mercaptoethanol2 mM 2-Mercaptoethanol?

0.386

methoxatin10-20 ug/mL Methoxatin?